DekaBank Deutsche Girozentrale
ENTA icon

DekaBank Deutsche Girozentrale’s Enanta Pharmaceuticals ENTA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,950
Closed -$183K – 1394
2022
Q2 		$183K Hold
3,950
– – ﹤0.01% 1204
2022
Q1 		$273K Buy
3,950
+400
+11% +$26K ﹤0.01% 1160
2021
Q4 		$264K Buy
3,550
+100
+3% +$7.85K ﹤0.01% 1221
2021
Q3 		$194K Hold
3,450
– – ﹤0.01% 1216
2021
Q2 		$149K Hold
3,450
– – ﹤0.01% 1279
2021
Q1 		$165K Hold
3,450
– – ﹤0.01% 1216
2020
Q4 		$143K Hold
3,450
– – ﹤0.01% 1229
2020
Q3 		$152K Buy
+3,450
New +$167K ﹤0.01% 1086
2019
Q4 		– Sell
-3,550
Closed -$214K – 1162
2019
Q3 		$214K Sell
3,550
-3,550
-50% -$264K ﹤0.01% 850
2019
Q2 		$595K Buy
7,100
+2,700
+61% +$243K ﹤0.01% 895
2019
Q1 		$396K Buy
4,400
+850
+24% +$76.2K ﹤0.01% 952
2018
Q4 		$253K Sell
3,550
-850
-19% -$65.2K ﹤0.01% 931
2018
Q3 		$396K Sell
4,400
-100
-2% -$10K ﹤0.01% 974
2018
Q2 		$508K Hold
4,500
– – ﹤0.01% 902
2018
Q1 		$358K Sell
4,500
-100
-2% -$7.7K ﹤0.01% 919
2017
Q4 		$183K Hold
4,600
– – ﹤0.01% 945
2017
Q3 		$183K Hold
4,600
– – ﹤0.01% 951
2017
Q2 		$167K Hold
4,600
– – ﹤0.01% 941
2017
Q1 		$144K Sell
4,600
-400
-8% -$12.5K ﹤0.01% 878
2016
Q4 		$168K Buy
+5,000
New +$143K ﹤0.01% 852
2016
Q2 		– Sell
-8,000
Closed -$228K – 1010
2016
Q1 		$228K Sell
8,000
-1,500
-16% -$41.8K ﹤0.01% 826
2015
Q4 		$318K Buy
9,500
+100
+1% +$3.26K ﹤0.01% 787
2015
Q3 		$340K Buy
9,400
+300
+3% +$12.9K ﹤0.01% 767
2015
Q2 		$409K Buy
9,100
+300
+3% +$11.7K ﹤0.01% 738
2015
Q1 		$269K Buy
+8,800
New +$342K ﹤0.01% 835

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ENTA Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Enanta Pharmaceuticals (ENTA) in Q3 2022, closing a stake of 3,950 shares — an estimated $183K sold.

DekaBank Deutsche Girozentrale first reported a position in ENTA in Q1 2015 and held it in 25 quarters. The position peaked at $595K in Q2 2019. 159 funds tracked by Wall St. Rank hold ENTA as of Q3 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Enanta Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 3,950 Enanta Pharmaceuticals shares in Q3 2022, an estimated $183K.
  • DekaBank Deutsche Girozentrale first reported a position in Enanta Pharmaceuticals in Q1 2015 and held it in 25 quarters.
  • DekaBank Deutsche Girozentrale's Enanta Pharmaceuticals position peaked at $595K in Q2 2019.
  • 159 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.